ZYDUS LIFESCIENCES LTD SCREENER.

IN

Narration Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24 Trailing Best Case Worst Case Total 10 years
Sales 8,651.30 9,426.80 9,376.50 11,904.90 13,165.60 14,253.10 14,403.50 15,109.90 17,237.40 19,547.40 19,547.40 22,166.97 21,155.27
Sales Growth 9% -1% 27% 11% 8% 1% 5% 14% 13%
Expenses 6,895.60 7,095.30 7,474.00 9,073.90 10,174.40 11,455.00 11,012.80 11,767.50 13,377.50 14,163.10 14,163.10 16,061.11 16,292.78
Expenses Growth 3% 5% 21% 12% 13% -4% 7% 14% 6%
Operating Profit 1,755.70 2,331.50 1,902.50 2,831.00 2,991.20 2,798.10 3,390.70 3,342.40 3,859.90 5,384.30 5,384.30 6,105.86 4,862.49
OPM% 20% 25% 20% 24% 23% 20% 24% 22% 22% 28% 28% 28% 23%
Other Income 45.00 112.10 127.30 110.90 183.00 -264.40 -231.10 2,581.40 -422.20 292.90 292.90 - - OI 2,535
Depreciation 287.30 292.10 373.30 538.80 598.60 696.50 669.60 713.00 722.70 764.10 764.10 764.10 764.10
Interest 67.90 52.80 44.60 91.10 193.50 341.80 158.80 127.00 129.90 81.20 81.20 81.20 81.20 Interest 1,289
Profit before tax 1,445.50 2,098.70 1,611.90 2,312.00 2,382.10 1,495.40 2,331.20 5,083.80 2,585.10 4,831.90 4,831.90 5,260.56 4,017.19
Tax 259.40 177.40 128.90 564.40 530.30 319.80 193.60 511.70 587.80 977.50 977.50 20% 20%
Net profit (PAT) 1,150.60 1,933.90 1,487.70 1,775.80 1,848.80 1,176.60 2,133.60 4,487.30 1,960.30 3,859.50 3,859.50 4,196.34 3,204.51 PAT 21814.10
NPM% 13% 21% 16% 15% 14% 8% 15% 30% 11% 20% 20% 19% 15%
Average NPM% 3 years 17% 17% 15% 12% 12% 18% 19% 20%
Cash From Operating Activity (CFO) 107.48 159.43 180.2 154.25 123.47 318.9 513.12 55.99 400.07 235.12 CFO 2248.03
Net Block / Net Fixed Asset (NFA) 3,352.20 3,747.90 5,755.10 6,482.60 12,163.70 12,230.50 12,132.80 12,188.50 11,520.90 12,368.50
Net Fixed Asset Turnover (NFAT) 2.66 1.97 1.95 1.41 1.17 1.18 1.24 1.45 1.64
Average NFAT 3 years 2.19 1.78 1.51 1.25 1.20 1.29 1.44
Dep% 0.09 0.08 0.06 0.08 0.05 0.06 0.06 0.06 0.06 0.06
Average Dep% 0.08 0.08 0.07 0.06 0.05 0.06 0.06 0.06
CWIP 797.90 950.80 1,543.30 1,527.20 837.20 741.50 783.20 725.90 1,200.70 2,423.30
Capex 840.70 2,973.00 1,250.20 5,589.70 667.60 613.60 711.40 529.90 2,834.30 (14,027.70) 764.10 764.10 Capex 16010.4
FCF (681.27) (2,792.80) (1,095.95) (5,466.23) (348.70) (100.48) (655.41) (129.83) (2,599.18) 14,027.70 (764.10) (764.10) FCF -13762
FCF Growth #DIV/0! 310% -61% 399% -94% -71% 552% -80% 1902% -640%
Total Debt 239.39 236.39 178.34 153.36 112 138.94 144.16 174.04 164.08 204.97
Share Capital 6 12 12.01 12.03 12.4 24.82 24.84 24.89 24.89 24.89
EPS 11.24 18.89 14.53 17.35 18.06 11.49 20.84 43.83 19.37 38.36 38.36 41.70 31.85 FCF - Int. (15,051)
EPS Growth 68% -23% 19% 4% -36% 81% 110% -56% 98%
Price to earning 30.99 16.77 30.41 21.78 19.22 23.25 21.15 7.95 25.38 26.26 30.76 30.76 21.97 FCF-Int. + OI (12,516)
PE Growth -85% 45% -40% -13% 17% -10% -166% 69% 3%
Price 348.36 316.90 442.00 377.85 347.05 267.25 440.90 348.50 491.55 1,007.35 1,180.00 1,282.98 699.68
Price Growth -9% 39% -15% -8% -23% 65% -21% 41% 105%
RATIOS:
Dividend Payout Ratio (DPR) 21.36% 16.94% 22.03% 20.18% 19.39% 30.46% 16.80% 5.70% 30.97% 7.82%
Average DPR 3 year 20.11% 19.72% 20.53% 23.34% 22.21% 17.65% 17.83% 14.83%
OPM 20.29% 24.73% 20.29% 23.78% 22.72% 19.63% 23.54% 22.12% 22.39% 27.54% 27.54%

Self-Sustainable Growth Rate (SSGR) 23% 15% 8% 7% 12% 14% 19%

TRENDS: 10 YEARS 7 YEARS 5 YEARS 3 YEARS RECENT BEST WORST

Sales Growth 9.48% 11.07% 8.23% 10.72% 13.40% 13.40% 8.23%
OPM 22.98% 23.29% 23.31% 24.25% 27.54% 27.54% 22.98%
Price to Earning 23.09 21.97 22.46 22.59 30.76 30.76 21.97
EPS Growth 15% 12% 27% -4% 98%
PE Growth Last 7 years 3%
PE Growth Last 5 years 2%
PE Growth Last 3 years 7%
Price Growth Preceding years 30% 42%
Profit Growth 24% 17% 21%
5 year PE based Intrinsic Value 1 1314
CMP 1180
Margin Safety 1 YES
3 year PE based Intrinsic Value 2 1036
Margin Safety 2 NO

Last 3 year Corr EPSgr vs PEgr Correlation EPSgr vs PEgr -0.731407907624064

EPSgr vs CMPgr Correlation EPSgr vs CMPgr 0.214488573975992 Based Price Gr 5 yrs Based Price Gr 3 yrs
Target Price Velocity 0.1X in 0.4 Years -0.1X in 0.3 Years
Consistency Sales Growth 119%
Consistency Profit Growth 268% Based Profit Gr 5 yrs Based Profit Gr 3 yrs Based Profit Recent Qtr
Consistency NFAT Growth 334% 0.1X in 0.5 Years -0.1X in -0.8 Years -0.1X in -0.7 Years
Consistency EPS Growth 48%
Consistency FCF Growth 53%
Consistency Target Price 49%
Consistency SSGR 244%
SSGR CAGR 19% 17%
NFAT Growth -1% 6%
Correlation NPM% vs Price Growth -0.0606256017798459 -0.535208246164893

As of Last Year
5 year PE based Intrinsic Value 1 641 -0.5X in -2.9 Years -0.6X in -2.9 Years
3 year PE based Intrinsic Value 2 505 -0.5X in -3.7 Years -0.6X in -6.4 Years
Last Year CMP after March 1400

QUALIFICATION RULES
1 SSGR 3 CAGR > SG 3 CAGR Fail
2 SG 3 CAGR Fail
3 SG 5 CAGR Fail
4 NPMgr 3 CAGR Pass
5 Correlation EPS vs CMPgr Fail
6 Correlation NPM vs Price Pass
7 ROCE 3 CAGR > 15% Pass
8 Average SSGR > Avg SG Pass
9 FCF > CFO Fail
10 Mgmt Promoter Holding
SIGNAL TEST Fail

_x000D_ Confidential (C)

#
ZYDUS LIFESCIENCES LTD SCREENER.IN

Narration Dec-21 Mar-22 Jun-22 Sep-22 Dec-22 Mar-23 Jun-23 Sep-23 Dec-23 Mar-24
Sales 3,639.80 3,805.60 4,072.70 4,134.70 4,257.10 5,010.60 5,139.60 4,368.80 4,505.20 5,533.80
Expenses 2,888.20 3,087.90 3,239.70 3,319.40 3,301.10 3,755.00 3,634.30 3,222.70 3,402.80 3,903.30
Operating Profit 751.60 717.70 833.00 815.30 956.00 1,255.60 1,505.30 1,146.10 1,102.40 1,630.50
Other Income 54.20 64.10 54.70 49.90 38.90 -565.70 20.80 53.00 59.50 159.60
Depreciation 177.00 185.40 180.70 181.80 181.60 178.60 179.80 184.20 194.80 205.30
Interest 31.10 38.50 34.30 35.10 32.80 27.70 18.10 8.70 19.80 34.60
Profit before tax 597.70 557.90 672.70 648.30 780.50 483.60 1,328.20 1,006.20 947.30 1,550.20
Tax 109.40 109.20 118.40 137.00 195.20 137.20 216.10 226.40 213.80 321.20
Net profit 500.40 397.40 518.30 522.50 622.90 296.60 1,086.90 800.70 789.60 1,182.30
NPM% 14% 10% 13% 13% 15% 6% 21% 18% 18% 21%
OPM 21% 19% 20% 20% 22% 25% 29% 26% 24% 29%

_x000D_ Confidential (C)

#
ZYDUS LIFESCIENCES LTD SCREENER.IN

Narration Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24
Equity Share Capital 102.40 102.40 102.40 102.40 102.40 102.40 102.40 102.40 101.20 100.60
Reserves 4,149.20 5,596.80 6,857.60 8,642.10 10,283.90 10,273.30 12,889.90 16,897.20 17,414.60 19,728.90
Borrowings 2,651.30 2,442.00 5,207.20 5,406.70 7,899.40 7,986.40 4,607.60 4,220.90 1,194.90 804.20
Other Liabilities 2,144.20 2,208.50 2,937.10 3,632.00 4,945.10 5,114.60 6,165.10 6,421.10 6,851.30 8,200.60
Total 9,047.10 10,349.70 15,104.30 17,783.20 23,230.80 23,476.70 23,765.00 27,641.60 25,562.00 28,834.30

Net Block 3,352.20 3,747.90 5,755.10 6,482.60 12,163.70 12,230.50 12,132.80 12,188.50 11,520.90 12,368.50
Capital Work in Progress 797.90 950.80 1,543.30 1,527.20 837.20 741.50 783.20 725.90 1,200.70 2,423.30
Investments 154.40 416.20 434.80 745.70 673.50 765.00 830.10 3,288.00 1,546.60 1,220.50
Other Assets 4,742.60 5,234.80 7,371.10 9,027.70 9,556.40 9,739.70 10,018.90 11,439.20 11,293.80 12,822.00
Total 9,047.10 10,349.70 15,104.30 17,783.20 23,230.80 23,476.70 23,765.00 27,641.60 25,562.00 28,834.30

Working Capital 2,598.40 3,026.30 4,434.00 5,395.70 4,611.30 4,625.10 3,853.80 5,018.10 4,442.50 4,621.40
Debtors 1,588.40 1,746.60 2,277.50 3,206.30 3,950.80 3,663.20 3,127.30 3,340.30 4,416.80 5,220.20
Inventory 1,535.70 1,337.10 1,803.70 2,385.30 2,688.00 2,789.00 3,236.20 3,719.40 3,413.30 3,441.90

Debtor Days 67.01 67.63 88.66 98.30 109.53 93.81 79.25 80.69 93.53 97.47
Inventory Turnover 5.63 7.05 5.20 4.99 4.90 5.11 4.45 4.06 5.05 5.68

Return on Equity 27% 34% 21% 20% 18% 11% 16% 26% 11% 19%
Return on Capital Emp 29% 16% 18% 16% 10% 14% 27% 14% 25%

_x000D_ Confidential (C)

#
ZYDUS LIFESCIENCES LTD SCREENER.IN

Narration Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24
Cash from Operating Activity 993.60 1,893.50 1,311.70 919.30 1,281.90 2,931.50 3,293.90 2,104.50 2,688.80 3,227.90
Cash from Investing Activity -464.70 -859.60 -2,871.90 -973.70 -3,977.40 -1,004.40 -836.70 -1,017.60 1,541.60 -1,492.30
Cash from Financing Activity -351.10 -934.80 2,315.80 51.50 1,884.60 -1,528.20 -2,547.70 -868.30 -4,400.40 -1,810.40
Net Cash Flow 177.80 99.10 755.60 -2.90 -810.90 398.90 -90.50 218.60 -170.00 -74.80

_x000D_ Confidential (C)

#
How to use it?
You can customize this workbook as you want.
You can add custom formating, add conditional formating, add your own formulas… do ANYTHING.
Please don't edit the "Data Sheet" only.

After customization, you can upload this back on Screener.

Upload on: https://www.screener.in/excel/

Download your customized workbooks now onwards.

Now whenever you will "Export to excel" from Screener, it will export your customized file.

TESTING:
This is a testing feature currently.
You can report any formula errors on the worksheet at: support@screener.in

_x000D_ Confidential (C)

#
as… do ANYTHING.

_x000D_ Confidential (C)

#
COMPANY NAME ZYDUS LIFESCIENCES LTD
LATEST VERSION 2.10 PLEA
CURRENT VERSION 2.10

META
Number of shares 100.62
Face Value 1.00
Current Price 1,180.00
Market Capitalization 118,735.60

PROFIT & LOSS

Report Date Mar-15 Mar-16 Mar-17 Mar-18
Sales 8,651.30 9,426.80 9,376.50 11,904.90
Raw Material Cost 3,293.70 3,107.00 3,557.70 4,437.40
Change in Inventory 97.10 11.10 138.80 315.40
Power and Fuel 159.20 168.80 174.50 226.30
Other Mfr. Exp 368.30 303.00 339.70 410.30
Employee Cost 1,238.70 1,302.80 1,523.40 1,862.10
Selling and admin 1,493.20 1,785.00 1,610.40 1,937.10
Other Expenses 439.60 439.80 407.10 516.10
Other Income 45.00 112.10 127.30 110.90
Depreciation 287.30 292.10 373.30 538.80
Interest 67.90 52.80 44.60 91.10
Profit before tax 1,445.50 2,098.70 1,611.90 2,312.00
Tax 259.40 177.40 128.90 564.40
Net profit 1,150.60 1,933.90 1,487.70 1,775.80
Dividend Amount 245.76 327.68 327.68 358.40

Quarters
Report Date Dec-21 Mar-22 Jun-22 Sep-22
Sales 3,639.80 3,805.60 4,072.70 4,134.70
Expenses 2,888.20 3,087.90 3,239.70 3,319.40
Other Income 54.20 64.10 54.70 49.90
Depreciation 177.00 185.40 180.70 181.80
Interest 31.10 38.50 34.30 35.10
Profit before tax 597.70 557.90 672.70 648.30
Tax 109.40 109.20 118.40 137.00
Net profit 500.40 397.40 518.30 522.50
Operating Profit 751.60 717.70 833.00 815.30

_x000D_ Confidential (C)

#
BALANCE SHEET
Report Date Mar-15 Mar-16 Mar-17 Mar-18
Equity Share Capital 102.40 102.40 102.40 102.40
Reserves 4,149.20 5,596.80 6,857.60 8,642.10
Borrowings 2,651.30 2,442.00 5,207.20 5,406.70
Other Liabilities 2,144.20 2,208.50 2,937.10 3,632.00
Total 9,047.10 10,349.70 15,104.30 17,783.20
Net Block 3,352.20 3,747.90 5,755.10 6,482.60
Capital Work in Progress 797.90 950.80 1,543.30 1,527.20
Investments 154.40 416.20 434.80 745.70
Other Assets 4,742.60 5,234.80 7,371.10 9,027.70
Total 9,047.10 10,349.70 15,104.30 17,783.20
Receivables 1,588.40 1,746.60 2,277.50 3,206.30
Inventory 1,535.70 1,337.10 1,803.70 2,385.30
Cash & Bank 669.90 638.70 1,543.50 1,314.90
No. of Equity Shares ### ### ### ###
New Bonus Shares
Face value 5.00 1.00 1.00 1.00

CASH FLOW:
Report Date Mar-15 Mar-16 Mar-17 Mar-18
Cash from Operating Activity 993.60 1,893.50 1,311.70 919.30
Cash from Investing Activity -464.70 -859.60 -2,871.90 -973.70
Cash from Financing Activity -351.10 -934.80 2,315.80 51.50
Net Cash Flow 177.80 99.10 755.60 -2.90

PRICE: 348.36 316.90 442.00 377.85

DERIVED:
Adjusted Equity Shares in Cr 102.37 102.37 102.37 102.37

_x000D_ Confidential (C)

#
 PLEASE DO NOT MAKE ANY CHANGES TO THIS SHEET

Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24

13,165.60 14,253.10 14,403.50 15,109.90 17,237.40 19,547.40
4,826.10 5,013.80 4,958.30 5,907.50 6,072.00 6,478.40
109.70 93.80 156.20 362.30 -238.10 250.20
247.20 268.80 246.90 315.00 361.60 384.80
505.40 526.50 500.50 497.10 472.20 528.50
2,130.70 2,399.10 2,298.60 2,437.60 2,769.40 3,141.50
1,963.70 2,381.50 2,233.90 2,207.10 2,694.10 2,842.80
611.00 959.10 930.80 765.50 770.10 1,037.30
183.00 -264.40 -231.10 2,581.40 -422.20 292.90
598.60 696.50 669.60 713.00 722.70 764.10
193.50 341.80 158.80 127.00 129.90 81.20
2,382.10 1,495.40 2,331.20 5,083.80 2,585.10 4,831.90
530.30 319.80 193.60 511.70 587.80 977.50
1,848.80 1,176.60 2,133.60 4,487.30 1,960.30 3,859.50
358.40 358.40 358.40 256.00 607.20 301.80

Dec-22 Mar-23 Jun-23 Sep-23 Dec-23 Mar-24

4,257.10 5,010.60 5,139.60 4,368.80 4,505.20 5,533.80
3,301.10 3,755.00 3,634.30 3,222.70 3,402.80 3,903.30
38.90 -565.70 20.80 53.00 59.50 159.60
181.60 178.60 179.80 184.20 194.80 205.30
32.80 27.70 18.10 8.70 19.80 34.60
780.50 483.60 1,328.20 1,006.20 947.30 1,550.20
195.20 137.20 216.10 226.40 213.80 321.20
622.90 296.60 1,086.90 800.70 789.60 1,182.30
956.00 1,255.60 1,505.30 1,146.10 1,102.40 1,630.50

_x000D_ Confidential (C)

#
Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24
102.40 102.40 102.40 102.40 101.20 100.60
10,283.90 10,273.30 12,889.90 16,897.20 17,414.60 19,728.90
7,899.40 7,986.40 4,607.60 4,220.90 1,194.90 804.20
4,945.10 5,114.60 6,165.10 6,421.10 6,851.30 8,200.60
23,230.80 23,476.70 23,765.00 27,641.60 25,562.00 28,834.30
12,163.70 12,230.50 12,132.80 12,188.50 11,520.90 12,368.50
837.20 741.50 783.20 725.90 1,200.70 2,423.30
673.50 765.00 830.10 3,288.00 1,546.60 1,220.50
9,556.40 9,739.70 10,018.90 11,439.20 11,293.80 12,822.00
23,230.80 23,476.70 23,765.00 27,641.60 25,562.00 28,834.30
3,950.80 3,663.20 3,127.30 3,340.30 4,416.80 5,220.20
2,688.00 2,789.00 3,236.20 3,719.40 3,413.30 3,441.90
548.90 964.90 888.30 1,106.90 573.10 1,105.10
### ### ### ### ### ###

1.00 1.00 1.00 1.00 1.00 1.00

Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24

1,281.90 2,931.50 3,293.90 2,104.50 2,688.80 3,227.90
-3,977.40 -1,004.40 -836.70 -1,017.60 1,541.60 -1,492.30
1,884.60 -1,528.20 -2,547.70 -868.30 -4,400.40 -1,810.40
-810.90 398.90 -90.50 218.60 -170.00 -74.80

347.05 267.25 440.90 348.50 491.55 1,007.35

102.37 102.37 102.37 102.37 101.22 100.62

_x000D_ Confidential (C)

#